![](/images/2013/post-sep.jpg)
Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Date of authorisation: 10/05/2012, Revision: 23, Status: Expired
This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
![](https://pharmaceuticals.einnews.com/tracking/article.gif?aid=726628504§ion=ema.europa.eu&a=mOk5vVpMj6CrICjh&i=dZ00B9-FrwnR03pG)
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.